Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility s ...

Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

Cook Medical announced the launch of its Interventional MRI (iMRI) division, which will collaborate with physicians, ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.

Access to better care, rapid intervention, and standardized procedures with predictable outcomes is critical for treating ...

However, this is the past; this article details the present and the near future. Several platforms have been evaluated in ...

Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...